MedPath

A General Clinical Pharmacological Study of TRK-820 Soft Capsules - Refractory Pruritus in Patients on Peritoneal Dialysis

Phase 3
Conditions
Intractable Pruritus in Patients on Peritoneal Dialysis
Registration Number
JPRN-jRCT2080222514
Lead Sponsor
Toray Industries,Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1)Patients on Peritoneal Dialysis
(2)It can be confirmed that the treatment of pruritus with existing therapies such as antihistamines or antiallergics has not been adequately effective in such patients

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the VAS values
Secondary Outcome Measures
NameTimeMethod
Changes in the VAS values, Changes in the itching scores, Mean VAS values, Mean itching scores, VAS improvement degree
© Copyright 2025. All Rights Reserved by MedPath